Results 211 to 220 of about 257,222 (353)

Intrahepatic bile duct adenoma in a patient with gastric cancer [PDF]

, 2018
Tsutomu Namikawa, Sachi Tsuda, Kazune Fujisawa, Eri Munekage, Jun Iwabu, Masaya Munekage, Sunao Uemura, Shigehiro Tsujii, Hiromichi Maeda, Hiroyuki Kitagawa, Mitsuko Iguchi, Ichiro Murakami, Michiya Kobayashi, Kazuhiro Hanazaki   +13 more
openalex   +1 more source

Perihilar Bile Duct Cancer pT0 TNM Finding v7 [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Liver Stiffness Characterization of OGTLKO Mouse Model of Progressive Liver Fibrosis

Journal of Ultrasound in Medicine, EarlyView.
Objectives O‐GlcNAcylation plays a key regulatory role in hepatic physiology, and its disruption leads to fibrosis in liver‐specific OGT knockout mice (OGTLKO), making this model valuable for studying advanced metabolic dysfunction‐associated steatohepatitis (MASH).
Gilles Renault, Lenin Chinchilla, Lourdes Massengo, Pierre Monbernard, Fadila Benhamed, Marion Regnier, Raphael Denis, Catherine Postic, Anthony Novell, Jean‐Luc Gennisson   +9 more
wiley   +1 more source

Mechanistic insights into liver-fluke-induced bile-duct cancer. [PDF]

Trends Parasitol
Smout MJ, Laha T, Chaiyadet S, Brindley PJ, Loukas A.   +4 more
europepmc   +1 more source

Total Bilirubin Levels as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer: Correspondence. [PDF]

Korean J Radiol, 2022
Sookaromdee P, Wiwanitkit V.
europepmc   +1 more source

Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

Medicine Bulletin, EarlyView.
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley   +1 more source

Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database. [PDF]

Cancers (Basel)
Danpanichkul P, Pang Y, Auttapracha T, Al Ta'ani O, Suenghataiphorn T, Kaewdech A, Muthiah MD, Kim D, Wijarnpreecha K, Singal AG, Yang JD.   +10 more
europepmc   +1 more source

Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer. [PDF]

Korean J Radiol, 2022
Hwang JA, Min JH, Kim SH, Choi SY, Lee JE, Moon JY.   +5 more
europepmc   +1 more source

57P Integrative analysis of the genomic and transcriptomic landscape identifies ciliary genes as a therapeutic target in bile duct cancer [PDF]

Pietro Carotenuto, F. Piscopo, Anna Barbato, Carla Pollastro, Luigi Ferrante, Laura Evangelista, Giorgia Gitano, Adriana Iuliano, P. Pisapia, Maria Salatiello, Antonino Iaccarino, U. Malapelle, G. Troncone, Giulia Grisendi, Luca Reggiani Bonetti, Massimiliano Salati, Marco De Dominici, Franco Bazzoli   +17 more
openalex   +1 more source

The Contribution of Cholesterol and Squalene Synthase in Cancer: Molecular Mechanisms, Lipid Rafts and Therapeutic Approaches

Medicinal Research Reviews, EarlyView.
ABSTRACT A plethora of cellular signaling pathways are dysregulated in cancer cells, promoting carcinogenesis and migration. Cholesterol has recently been linked to cancer by several subcellular mechanisms, especially by its involvement in the formation of lipid rafts, which promote oncogenic signaling and cancer cell invasion. Squalene synthase (SQS),
Danai Mavridi, Theodora Katavati, Angeliki P. Kourounakis   +2 more
wiley   +1 more source